Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announces it has signed its first licensing partnership agreement in Canada with Wellbeings Pain Management and Dependency Clinic (Wellbeings). The agreement will enable Ontario based Wellbeings, who are focused on multi-disciplinary,…